Literature DB >> 30422324

Key microRNAs in the biology of breast cancer; emerging evidence in the last decade.

Monireh Khordadmehr1, Roya Shahbazi1, Hamed Ezzati1, Farinaz Jigari-Asl1, Sanam Sadreddini2, Behzad Baradaran2.   

Abstract

microRNAs (miRNAs) are a family of small noncoding RNAs that play a pivotal role in the regulation of main biological and physiological processes, including cell cycle regulation, proliferation, differentiation, apoptosis, stem cell maintenance, and organ development. Dysregulation of these tiny molecules has been related to different human diseases, such as cancer. It has been estimated that more than 50% of these noncoding RNA sequences are placed on fragile sites or cancer-associated genomic regions. After the discovery of the first specific miRNA signatures in breast cancer, many studies focused on the involvement of these small RNAs in the pathophysiology of breast tumors and their possible clinical implications as reliable prognostic biomarkers or as a new therapeutic approach. Therefore, the present review will focus on the recent findings on the involvement of miRNAs in the biology of breast cancer associated with their clinical implications.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  biology; breast cancer (BC); dysregulation; microRNAs (miRNAs); target

Mesh:

Substances:

Year:  2018        PMID: 30422324     DOI: 10.1002/jcp.27716

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  15 in total

Review 1.  MicroRNAs in Bone Metastasis.

Authors:  Eric Hesse; Hanna Taipaleenmäki
Journal:  Curr Osteoporos Rep       Date:  2019-06       Impact factor: 5.096

2.  MicroRNA-451a targets caveolin-1 in stomach cancer cells.

Authors:  Yi Wang; Zhenmeng Lin; Jintian Song; Shenghong Wei; Zaisheng Ye; Shu Chen; Yi Zeng; Zhitao Lin; Xiaoling Chen; Luchuan Chen
Journal:  Int J Clin Exp Pathol       Date:  2020-10-01

Review 3.  A review of prognostic and predictive biomarkers in breast cancer.

Authors:  Elaheh Tarighati; Hadi Keivan; Hojjat Mahani
Journal:  Clin Exp Med       Date:  2022-01-15       Impact factor: 3.984

4.  Aberrant Methylation of 21 MicroRNA Genes in Breast Cancer: Sets of Genes Associated with Progression and a System of Markers for Predicting Metastasis.

Authors:  V I Loginov; A M Burdennyy; E A Filippova; I V Pronina; S S Lukina; T P Kazubskaya; A V Karpukhin; D S Khodyrev; E A Braga
Journal:  Bull Exp Biol Med       Date:  2021-11-18       Impact factor: 0.804

5.  Optimized Marker System for Early Diagnosis of Breast Cancer.

Authors:  A M Burdennyy; E A Filippova; D S Khodyrev; I V Pronina; S S Lukina; N A Ivanova; T P Kazubskaya; V I Loginov; E A Braga
Journal:  Bull Exp Biol Med       Date:  2021-11-18       Impact factor: 0.804

6.  MicroRNA-205-5p inhibits three-dimensional spheroid proliferation of ErbB2-overexpressing breast epithelial cells through direct targeting of CLCN3.

Authors:  Takayoshi Takeno; Takuya Hasegawa; Hiroki Hasegawa; Yasuyuki Ueno; Ryo Hamataka; Aya Nakajima; Junji Okubo; Koji Sato; Toshiyuki Sakamaki
Journal:  PeerJ       Date:  2019-10-08       Impact factor: 2.984

7.  miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3.

Authors:  Bao Zhang; Dattatrya Shetti; Conghui Fan; Kun Wei
Journal:  Biol Res       Date:  2019-07-26       Impact factor: 5.612

8.  Integrated Bioinformatics Data Analysis Reveals Prognostic Significance Of SIDT1 In Triple-Negative Breast Cancer.

Authors:  Ya Wang; Hanning Li; Jingjing Ma; Tian Fang; Xiaoting Li; Jiahao Liu; Henok Kessete Afewerky; Xiong Li; Qinglei Gao
Journal:  Onco Targets Ther       Date:  2019-10-11       Impact factor: 4.147

9.  Age-related increase of kynurenine enhances miR29b-1-5p to decrease both CXCL12 signaling and the epigenetic enzyme Hdac3 in bone marrow stromal cells.

Authors:  Ahmed M Elmansi; Khaled A Hussein; Sergio Mas Herrero; Sudharsan Periyasamy-Thandavan; Alexandra Aguilar-Pérez; Galina Kondrikova; Dmitry Kondrikov; Nada H Eisa; Jessica L Pierce; Helen Kaiser; Ke-Hong Ding; Aisha L Walker; Xue Jiang; Wendy B Bollag; Mohammed Elsalanty; Qing Zhong; Xing-Ming Shi; Yun Su; Maribeth Johnson; Monte Hunter; Charles Reitman; Brian F Volkman; Mark W Hamrick; Carlos M Isales; Sadanand Fulzele; Meghan E McGee-Lawrence; William D Hill
Journal:  Bone Rep       Date:  2020-04-23

10.  The Potential Diagnostic Accuracy of Let-7 Family for Cancer: A Meta-Analysis.

Authors:  Wen-Ting Zhang; Guo-Xun Zhang; Shuai-Shuai Gao
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.